EMEA-001809-PIP01-15-M01
Key facts
| Active substance |
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0173/2019
|
| PIP number |
EMEA-001809-PIP01-15-M01
|
| Pharmaceutical form(s) |
Powder for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of Gram-negative bacterial infections
|
| Route(s) of administration |
Parenteral use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
Belgium |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|